Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-23-016518
Filing Date
2023-10-18
Accepted
2023-10-18 16:46:57
Documents
14
Period of Report
2023-10-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A olma-20231013x8ka.htm   iXBRL 8-K/A 43706
2 EX-99.1 olma-20231013xex99d1.htm EX-99.1 11334
3 GRAPHIC olma-20231013xex99d1002.jpg GRAPHIC 7606
  Complete submission text file 0001558370-23-016518.txt   193765

Data Files

Seq Description Document Type Size
4 EX-101.SCH olma-20231013.xsd EX-101.SCH 3123
5 EX-101.LAB olma-20231013_lab.xml EX-101.LAB 15895
6 EX-101.PRE olma-20231013_pre.xml EX-101.PRE 10106
8 EXTRACTED XBRL INSTANCE DOCUMENT olma-20231013x8ka_htm.xml XML 5385
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39712 | Film No.: 231332636
SIC: 2834 Pharmaceutical Preparations